Litcius/Paper detail

OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer

S. Supiot, Loïg Vaugier, David Pasquier, Xavier Buthaud, Nicolas Magné, D. Peiffert, Paul Sargos, G. Créhange, P. Pommier, G. Loos, Ali Hasbini, I. Latorzeff, Marlon Silva, Fabrice Denis, Jean‐Léon Lagrange, Cyrille Morvan, L. Campion, Audrey Blanc-Lapierre

2021European Urology91 citationsDOIOpen Access PDF

Topics & Concepts

MedicineProstate cancerSalvage therapyRadiation therapyClinical endpointAndrogen deprivation therapyHormonal therapyProstateUrologyInternal medicineOncologySurgeryCancerRandomized controlled trialChemotherapyProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchUrinary Bladder and Prostate Research
OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer | Litcius